Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs/symptoms of pneumonia. Immunosuppressed.
The UK pharma’s ageing Advair inhaler, still a mainstay of GSK's respiratory portfolio, is threatened by generic competition ... approved combinations Relvar/Breo Ellipta and Anoro Ellipta.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback